Cargando…

2+0 CYP21A2 deletion carrier — a limitation of the genetic testing and counseling: A case report

BACKGROUND: CYP21A2 gene mutations may all cause reduction or loss of 21-hydroxylase activity, leading to development of congenital adrenal hyperplasia (CAH) with different clinical phenotypes. For families with CAH children, genetic testing of the parents and genetic counseling are recommended to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Na, Song, Xiao, Wang, Xue-Yan, Qin, Sheng-Fang, He, Guan-Nan, Sun, Ling-Ling, Chen, Xi-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362542/ https://www.ncbi.nlm.nih.gov/pubmed/34447826 http://dx.doi.org/10.12998/wjcc.v9.i23.6789

Ejemplares similares

Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
por: Coeli, Fernanda B, et al.
Publicado: (2010)

Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
por: Silva, Rita Santos, et al.
Publicado: (2022)

Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera
por: Lao, Qizong, et al.
Publicado: (2023)

Detection of Small CYP11B1 Deletions and One Founder Chimeric CYP11B2/CYP11B1 Gene in 11β-Hydroxylase Deficiency
por: Xie, Hua, et al.
Publicado: (2022)

17-Hydroxyprogesterone Response to Standard Dose Synacthen Stimulation Test in CYP21A2 Heterozygous Carriers and Non-carriers in Symptomatic and Asymptomatic Groups: Meta-analyses
por: Polat, Seher, et al.
Publicado: (2022)

Deletion of the Murine Cytochrome P450 Cyp2j Locus by Fused BAC-Mediated Recombination Identifies a Role for Cyp2j in the Pulmonary Vascular Response to Hypoxia
por: Zhou, Guo Ling, et al.
Publicado: (2013)

Identification of a novel compound heterozygous mutation of the CYP21A2 gene causing 21-hydroxylase deficiency in a Chinese pedigree
por: Liu, Jia, et al.
Publicado: (2018)

Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia
por: Nasir, Hamza, et al.
Publicado: (2018)

Simple and Robust Detection of CYP2D6 Gene Deletions and Duplications Using CYP2D8P as Reference
por: Larsen, Jens Borggaard, et al.
Publicado: (2022)

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
por: Neocleous, Vassos, et al.
Publicado: (2014)

Pregnanetriol in the Range of 1.2–2.1 mg/m(2)/day as an Index of Optimal Control in CYP21A2 Deficiency
por: Izawa, Masako, et al.
Publicado: (2007)

Inhibitory Potency of 8-Methoxypsoralen on Cytochrome P450 2A6 (CYP2A6) Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22: Differential Susceptibility Due to Different Sequence Locations of the Mutations
por: Tiong, Kai Hung, et al.
Publicado: (2014)

Association of CYP2A6 gene deletion with cancers in Japanese elderly: an autopsy study
por: Abudushataer, Maidina, et al.
Publicado: (2020)

Association of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults
por: Ando, Masahiko, et al.
Publicado: (2007)

Dual Heterozygous Mutations in CYP21A2 and CYP11B1 in a Case of Nonclassic Congenital Adrenal Hyperplasia
por: Frontera, Eric D., et al.
Publicado: (2022)

A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form
por: Concolino, Paola, et al.
Publicado: (2009)

A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China – A Basis for Personalized Therapy
por: Wu, Zhenqiang, et al.
Publicado: (2013)

Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
por: Chi, Dung V., et al.
Publicado: (2019)

Variations in the 3′UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia
por: Neocleous, Vassos, et al.
Publicado: (2017)

Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations
por: Prado, Mayara J., et al.
Publicado: (2021)

Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
por: Prado, Mayara J., et al.
Publicado: (2022)

H62L Mutation of CYP21A2 Identified in the Non-classical Form of 21-Hydroxylase Deficiency
por: Nagasaki, Keisuke, et al.
Publicado: (2009)

Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency
por: Anastasovska, Violeta, et al.
Publicado: (2015)

Data on the 21-Hydroxylase deficient CAH patients and the identification of known/novel mutations in CYP21A2 gene
por: Khajuria, Ragini, et al.
Publicado: (2016)

Comprehensive Genetic Testing of CYP21A2: A Retrospective Analysis in Patients with Suspected Congenital Adrenal Hyperplasia
por: Nan, Madalina Nicoleta, et al.
Publicado: (2021)

In vitro and In silico studies of interactions of cathinone with human recombinant cytochrome P450 CYP(1A2), CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2, and CYP3A5
por: Lim, Sharoen Yu Ming, et al.
Publicado: (2022)

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up
por: Ponder, B
Publicado: (2000)

Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
por: Koda, Masahide, et al.
Publicado: (2017)

Classification and genetic counselling for a novel splicing mutation of the MLH1 intron associated with Lynch syndrome in colorectal cancer
por: Wang, Ling-Ling, et al.
Publicado: (2021)

A de novo mutation in CYP21A2 gene in a case of in vitro fertilization
por: Silva-Grecco, Roseane Lopes da, et al.
Publicado: (2015)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
por: Bojić, Mirza, et al.
Publicado: (2019)

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers
por: Jessurun, Naomi T., et al.
Publicado: (2020)

Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
por: Marumudi, Eunice, et al.
Publicado: (2012)

Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene
por: Rabbani, Bahareh, et al.
Publicado: (2011)

CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica
por: Umaña-Calderón, Andrés, et al.
Publicado: (2021)

The Associations of Androgen-Related Genes CYP21A2 and CYP19A1 with Severe Acne Vulgaris in Patients from Southwest China
por: Yang, Ting, et al.
Publicado: (2021)

PSAT047 Dual Heterozygous Mutations in CYP21A2 and CYP11B1 in a Case of Nonclassic Congenital Adrenal Hyperplasia
por: Frontera, Eric, et al.
Publicado: (2022)

CYP21A2 Gene Expression in a Humanized 21-Hydroxylase Mouse Model Does Not Affect Adrenocortical Morphology and Function
por: Schubert, Tina, et al.
Publicado: (2022)

The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l‐hydroxylase deficiency in a Chinese cohort
por: Liu, Yang, et al.
Publicado: (2020)

Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
por: Koda, Masahide, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u7mtksscbm00d2m4hv7tb1fbh1